Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Incyte Corp (INCY)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Incyte Corp.
Table 2 shows the detailed insider transactions.
This company's CIK number is 879169.
Total stock buying since 2015: $245,291,742.
Total stock sales since 2015: $343,905,944.
Total stock option exercises since 2015: $99,295,098.
Table 3. Detailed insider trading at Incyte Corp (INCY)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-09-02 | Denton Sheila A. (EVP & General Counsel) | Sale | 598 | 84.97 | 50,812 |
| 2025-09-02 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 598 | 58.06 | 34,719 |
| 2025-08-15 | Denton Sheila A. (EVP & General Counsel) | Sale | 277 | 86.81 | 24,046 |
| 2025-08-15 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 277 | 64.25 | 17,797 |
| 2025-08-04 | Denton Sheila A. (EVP & General Counsel) | Sale | 598 | 75.77 | 45,310 |
| 2025-08-04 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 598 | 58.06 | 34,719 |
| 2025-07-21 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 3,706 | 67.94 | 251,785 |
| 2025-07-16 | Denton Sheila A. (EVP & General Counsel) | Sale | 2,355 | 68.36 | 160,986 |
| 2025-07-16 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 2,949 | 68.36 | 201,591 |
| 2025-07-16 | Flannelly Barry P (EVP & General Manager US) | Sale | 4,020 | 68.36 | 274,806 |
| 2025-07-15 | Denton Sheila A. (EVP & General Counsel) | Sale | 9,990 | 69.86 | 697,899 |
| 2025-07-15 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 9,990 | 64.25 | 641,856 |
| 2025-07-15 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 1,177 | 69.86 | 82,225 |
| 2025-07-15 | Flannelly Barry P (EVP & General Manager US) | Sale | 1,192 | 69.86 | 83,273 |
| 2025-07-14 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 14,952 | 68.47 | 1,023,763 |
| 2025-07-03 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 8,617 | 68.16 | 587,291 |
| 2025-07-03 | Flannelly Barry P (EVP & General Manager US) | Sale | 10,903 | 68.15 | 743,039 |
| 2025-07-02 | Denton Sheila A. (EVP & General Counsel) | Sale | 599 | 68.61 | 41,097 |
| 2025-07-02 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 599 | 58.06 | 34,777 |
| 2025-06-03 | Denton Sheila A. (EVP & General Counsel) | Sale | 1,795 | 68.00 | 122,060 |
| 2025-06-03 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 1,795 | 58.06 | 104,217 |
| 2025-06-02 | Tray Thomas (Principal Accounting Officer) | Sale | 651 | 64.88 | 42,236 |
| 2025-05-30 | Tray Thomas (Principal Accounting Officer) | Sale | 963 | 65.71 | 63,278 |
| 2025-03-14 | Flannelly Barry P (EVP & General Manager US) | Sale | 19,807 | 67.80 | 1,342,974 |
| 2025-03-04 | Denton Sheila A. (EVP & General Counsel) | Sale | 599 | 69.99 | 41,924 |
| 2025-03-04 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 599 | 58.06 | 34,777 |
| 2025-02-26 | Denton Sheila A. (EVP & General Counsel) | Sale | 14,069 | 74.08 | 1,042,161 |
| 2025-02-26 | Denton Sheila A. (EVP & General Counsel) | Option Ex | 9,574 | 58.06 | 555,866 |
| 2025-01-21 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 12,352 | 72.69 | 897,866 |
| 2024-12-16 | Tray Thomas (Principal Accounting Officer) | Sale | 650 | 69.31 | 45,051 |
| 2024-12-13 | Tray Thomas (Principal Accounting Officer) | Sale | 650 | 70.64 | 45,916 |
| 2024-11-29 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 6,043 | 75.48 | 456,155 |
| 2024-11-06 | Flannelly Barry P (EVP & General Manager US) | Sale | 3,680 | 80.11 | 294,786 |
| 2024-11-06 | Flannelly Barry P (EVP & General Manager US) | Option Ex | 3,680 | 70.44 | 259,237 |
| 2024-09-13 | Tray Thomas (Principal Accounting Officer) | Sale | 382 | 63.37 | 24,207 |
| 2024-09-12 | Tray Thomas (Principal Accounting Officer) | Sale | 572 | 62.94 | 36,001 |
| 2024-09-12 | Dickinson Jonathan Elliott (EVP, General Manager, Europe) | Sale | 8,450 | 62.34 | 526,730 |
| 2024-08-12 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 11,608 | 60.63 | 703,793 |
| 2024-07-25 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 15,571 | 70.00 | 1,089,970 |
| 2024-07-16 | Flannelly Barry P (EVP & General Manager US) | Sale | 1,306 | 64.19 | 83,832 |
| 2024-07-09 | Flannelly Barry P (EVP & General Manager US) | Sale | 8,148 | 60.00 | 488,880 |
| 2024-06-12 | Flannelly Barry P (EVP & General Manager US) | Sale | 19,164 | 60.00 | 1,149,840 |
| 2024-06-06 | Tray Thomas (Principal Accounting Officer) | Sale | 1,093 | 58.91 | 64,388 |
| 2024-05-07 | Baker Julian | Option Ex | 30,000 | 49.01 | 1,470,300 |
| 2024-01-03 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 7,365 | 65.51 | 482,481 |
| 2024-01-02 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 657 | 65.00 | 42,705 |
| 2023-12-13 | Tray Thomas (Principal Accounting Officer) | Sale | 1,067 | 62.37 | 66,548 |
| 2023-12-12 | Tray Thomas (Principal Accounting Officer) | Sale | 210 | 57.36 | 12,045 |
| 2023-09-01 | Swain Paula J (EVP, Human Resources) | Sale | 8,449 | 65.13 | 550,283 |
| 2023-08-01 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 21,511 | 63.28 | 1,361,216 |
| 2023-03-13 | Baker Felix (Director) | Option Ex | 40,000 | 22.74 | 909,599 |
| 2023-02-16 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 3,693 | 65.42 | 241,596 |
| 2023-01-31 | Pasquale Maria E (EVP & General Counsel) | Sale | 802 | 84.06 | 67,416 |
| 2023-01-31 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 802 | 74.78 | 59,973 |
| 2023-01-30 | Pasquale Maria E (EVP & General Counsel) | Sale | 60,024 | 84.77 | 5,088,234 |
| 2023-01-30 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 60,024 | 74.19 | 4,452,880 |
| 2023-01-26 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 2,419 | 85.00 | 205,615 |
| 2023-01-26 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 7,000 | 85.00 | 595,000 |
| 2023-01-26 | Iyengar Vijay K (EVP, GMAPPS) | Option Ex | 7,000 | 68.62 | 480,340 |
| 2023-01-04 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 28,399 | 79.78 | 2,265,672 |
| 2022-12-23 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 17,324 | 80.79 | 1,399,605 |
| 2022-12-23 | Iyengar Vijay K (EVP, GMAPPS) | Option Ex | 14,866 | 70.74 | 1,051,620 |
| 2022-12-19 | Tray Thomas (Principal Accounting Officer) | Sale | 1,223 | 82.16 | 100,481 |
| 2022-07-22 | Tray Thomas (Principal Accounting Officer) | Sale | 1,564 | 83.13 | 130,015 |
| 2022-07-07 | Iyengar Vijay K (EVP, GMAPPS) | Sale | 5,787 | 79.38 | 459,372 |
| 2022-07-07 | Flannelly Barry P (EVP & General Manager US) | Sale | 2,873 | 79.38 | 228,058 |
| 2022-04-08 | Flannelly Barry P (EVP & General Manager US) | Sale | 43,993 | 83.23 | 3,661,625 |
| 2022-04-08 | Flannelly Barry P (EVP & General Manager US) | Option Ex | 41,864 | 70.44 | 2,949,109 |
| 2022-03-10 | Baker Felix (Director) | Buy | 218,563 | 72.39 | 15,821,119 |
| 2022-03-09 | Baker Felix (Director) | Buy | 70,517 | 71.72 | 5,057,549 |
| 2022-03-08 | Baker Felix (Director) | Buy | 100,000 | 70.67 | 7,067,500 |
| 2022-03-08 | Baker Felix (Director) | Option Ex | 40,000 | 22.05 | 882,000 |
| 2022-02-22 | Baker Felix (Director) | Buy | 99,800 | 68.07 | 6,793,585 |
| 2022-02-18 | Baker Felix (Director) | Buy | 133,032 | 68.40 | 9,099,255 |
| 2022-02-17 | Baker Felix (Director) | Buy | 292,972 | 67.57 | 19,796,118 |
| 2022-01-31 | Dickinson Jonathan Elliott (EVP, General Manager, Europe) | Sale | 7,375 | 74.19 | 547,151 |
| 2022-01-07 | Swain Paula J (EVP, Human Resources) | Sale | 10,870 | 73.31 | 796,879 |
| 2022-01-07 | Swain Paula J (EVP, Human Resources) | Option Ex | 10,870 | 73.21 | 795,792 |
| 2022-01-04 | Swain Paula J (EVP, Human Resources) | Sale | 9,319 | 73.46 | 684,573 |
| 2022-01-04 | Swain Paula J (EVP, Human Resources) | Option Ex | 9,319 | 73.21 | 682,243 |
| 2022-01-03 | Trower Paul (Principal Accounting Officer) | Sale | 8,214 | 73.31 | 602,168 |
| 2022-01-03 | Trower Paul (Principal Accounting Officer) | Option Ex | 8,214 | 73.21 | 601,346 |
| 2021-12-23 | Dixon Wendy L (Director) | Sale | 20,000 | 22.05 | 441,000 |
| 2021-12-23 | Dixon Wendy L (Director) | Option Ex | 20,000 | 73.25 | 1,465,000 |
| 2021-12-17 | Baker Julian | Buy | 1,075,872 | 72.84 | 78,368,668 |
| 2021-12-16 | Baker Julian | Buy | 169,315 | 71.98 | 12,186,955 |
| 2021-12-15 | Baker Julian | Buy | 350,332 | 69.87 | 24,478,047 |
| 2021-10-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 389 | 68.67 | 26,712 |
| 2021-09-24 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 382 | 65.36 | 24,967 |
| 2021-09-20 | Swain Paula J (EVP, Human Resources) | Option Ex | 1,356 | 73.21 | 99,272 |
| 2021-09-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 388 | 76.71 | 29,763 |
| 2021-08-02 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 389 | 77.49 | 30,143 |
| 2021-07-29 | Iyengar Vijay K (EVP GPS, BD, & Licensing) | Sale | 4,911 | 78.29 | 384,482 |
| 2021-07-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 396 | 84.09 | 33,299 |
| 2021-06-18 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 255 | 65.36 | 16,666 |
| 2021-06-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 395 | 84.13 | 33,231 |
| 2021-05-03 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 396 | 85.40 | 33,818 |
| 2021-04-23 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 127 | 65.36 | 8,300 |
| 2021-04-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 396 | 81.57 | 32,301 |
| 2021-03-29 | Morrissey Michael James (EVP, Head of Tech. Operations) | Sale | 20,000 | 81.08 | 1,621,600 |
| 2021-03-12 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 128 | 65.36 | 8,366 |
| 2021-03-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 395 | 79.73 | 31,493 |
| 2021-02-23 | Hoppenot Herve (Chairman / CEO) | Buy | 12,925 | 77.37 | 1,000,007 |
| 2021-02-16 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 127 | 65.36 | 8,300 |
| 2021-02-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 1,356 | 90.00 | 122,040 |
| 2021-02-01 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 961 | 65.42 | 62,868 |
| 2021-01-25 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 3,795 | 100.00 | 379,500 |
| 2021-01-25 | Stein Steven H (EVP & Chief Medical Officer) | Option Ex | 3,795 | 68.62 | 260,412 |
| 2021-01-25 | Iyengar Vijay K (EVP GPS, BD, & Licensing) | Sale | 5,116 | 99.00 | 506,484 |
| 2021-01-25 | Iyengar Vijay K (EVP GPS, BD, & Licensing) | Option Ex | 4,116 | 72.86 | 299,891 |
| 2021-01-25 | Wenqing Yao (EVP, Head of Discovery Chem) | Sale | 21,545 | 100.00 | 2,154,500 |
| 2021-01-25 | Wenqing Yao (EVP, Head of Discovery Chem) | Option Ex | 21,545 | 73.21 | 1,577,309 |
| 2021-01-25 | Flannelly Barry P (EVP & General Manager US) | Sale | 2,744 | 100.00 | 274,400 |
| 2021-01-11 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 127 | 65.36 | 8,300 |
| 2020-12-11 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 128 | 65.36 | 8,366 |
| 2020-11-12 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 127 | 65.36 | 8,300 |
| 2020-11-10 | Bienaime Jean Jacques (Director) | Sale | 798 | 83.00 | 66,234 |
| 2020-11-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 961 | 85.17 | 81,848 |
| 2020-11-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 961 | 65.42 | 62,868 |
| 2020-11-02 | Flannelly Barry P (EVP & General Manager US) | Sale | 20,000 | 86.60 | 1,732,000 |
| 2020-11-02 | Flannelly Barry P (EVP & General Manager US) | Option Ex | 20,000 | 48.44 | 968,800 |
| 2020-10-12 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 128 | 65.36 | 8,366 |
| 2020-10-09 | Pasquale Maria E (EVP & General Counsel) | Sale | 1,423 | 95.00 | 135,185 |
| 2020-10-09 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 1,423 | 68.62 | 97,646 |
| 2020-10-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 961 | 91.97 | 88,383 |
| 2020-10-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 961 | 65.42 | 62,868 |
| 2020-09-11 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 127 | 65.36 | 8,300 |
| 2020-09-10 | Pasquale Maria E (EVP & General Counsel) | Sale | 2,193 | 90.83 | 199,190 |
| 2020-09-10 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 2,193 | 65.36 | 143,334 |
| 2020-09-08 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 961 | 88.94 | 85,471 |
| 2020-09-08 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 961 | 65.42 | 62,868 |
| 2020-08-27 | Dixon Wendy L (Director) | Sale | 20,000 | 94.51 | 1,890,200 |
| 2020-08-27 | Dixon Wendy L (Director) | Option Ex | 20,000 | 18.97 | 379,400 |
| 2020-08-10 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 128 | 65.36 | 8,366 |
| 2020-08-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 961 | 97.80 | 93,985 |
| 2020-08-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 961 | 65.42 | 62,868 |
| 2020-07-16 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 766 | 103.83 | 79,533 |
| 2020-07-13 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 2,419 | 65.42 | 158,250 |
| 2020-07-10 | Pasquale Maria E (EVP & General Counsel) | Option Ex | 127 | 65.36 | 8,300 |
| 2020-07-08 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 610 | 108.56 | 66,221 |
| 2020-07-08 | Iyengar Vijay K (EVP GPS, BD, & Licensing) | Sale | 475 | 108.56 | 51,566 |
| 2020-07-07 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 14,159 | 109.36 | 1,548,385 |
| 2020-07-07 | Stein Steven H (EVP & Chief Medical Officer) | Option Ex | 10,876 | 88.68 | 964,483 |
| 2020-07-07 | Iyengar Vijay K (EVP GPS, BD, & Licensing) | Sale | 3,120 | 107.98 | 336,897 |
| 2020-07-07 | Hoppenot Herve (Chairman / CEO) | Sale | 89,771 | 110.00 | 9,874,810 |
| 2020-07-07 | Hoppenot Herve (Chairman / CEO) | Option Ex | 89,771 | 73.21 | 6,572,134 |
| 2020-07-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Sale | 961 | 106.58 | 102,423 |
| 2020-07-06 | Dhanak Dashyant (EVP & Chief Scientific Officer) | Option Ex | 961 | 65.42 | 62,868 |
| 2020-07-06 | Stein Steven H (EVP & Chief Medical Officer) | Sale | 36,124 | 107.13 | 3,869,891 |
| 2020-07-06 | Stein Steven H (EVP & Chief Medical Officer) | Option Ex | 33,602 | 77.14 | 2,591,991 |
Insider trading activities including stock purchases, stock sales, and option exercises
of INCY listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Incyte Corp (symbol INCY,
CIK number 879169) see
the Securities and Exchange Commission (SEC) website.